Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...

Five-star-rated analyst Mark Mahaney at Evercore ISI has downgraded his rating from Buy to Hold on The Trade Desk (TTD) after ...

In a report released yesterday, Greg Melich from Evercore ISI maintained a Hold rating on Genuine Parts Company (GPC – Research Report), with a ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...

Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

The health chain is is working with Evercore for assistance as it explores options that include a sale or restructuring of ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

Evercore researchers noted ... especially among hyperscalelarge-scale cloud infrastructure providers. The company projects Nvidia to be five to ten years ahead of rivals like Advanced Micro ...